205 related articles for article (PubMed ID: 34890802)
21. National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.
George TJ; Franke AJ; Chakravarthy AB; Das P; Dasari A; El-Rayes BF; Hong TS; Kinsella TJ; Landry JC; Lee JJ; Monjazeb AM; Jacobs SA; Raben D; Rahma OE; Williams TM; Wu C; Coleman CN; Vikram B; Ahmed MM
Cancer; 2019 Aug; 125(16):2732-2746. PubMed ID: 31017664
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Chang JE; Khuntia D; Robins HI; Mehta MP
Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
[TBL] [Abstract][Full Text] [Related]
23. Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.
Alcorn S; Walker AJ; Gandhi N; Narang A; Wild AT; Hales RK; Herman JM; Song DY; Deweese TL; Antonarakis ES; Tran PT
Int J Mol Sci; 2013 Jul; 14(7):14800-32. PubMed ID: 23863691
[TBL] [Abstract][Full Text] [Related]
24.
Hu S; Xie D; Zhou P; Liu X; Yin X; Huang B; Guan H
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33693953
[TBL] [Abstract][Full Text] [Related]
25. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy.
Chen Y; Yang J; Fu S; Wu J
Int J Nanomedicine; 2020; 15():9407-9430. PubMed ID: 33262595
[TBL] [Abstract][Full Text] [Related]
26. Concurrent paclitaxel and radiation therapy for breast cancer.
Formenti SC; Symmans WF; Volm M; Skinner K; Cohen D; Spicer D; Danenberg PV
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):34-42. PubMed ID: 10210538
[TBL] [Abstract][Full Text] [Related]
27. Radiosensitization of prostate cancer by soy isoflavones.
Raffoul JJ; Sarkar FH; Hillman GG
Curr Cancer Drug Targets; 2007 Dec; 7(8):759-65. PubMed ID: 18220535
[TBL] [Abstract][Full Text] [Related]
28. Radiosensitization by the combination of SR-2508 and paclitaxel in hypoxic human tumor cells in vitro.
Jin C; Bai L; Guo G
J Radiat Res; 2007 May; 48(3):179-85. PubMed ID: 17420623
[TBL] [Abstract][Full Text] [Related]
29. [Radiosensitization research in cancer therapy].
Sugahara T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):405-11. PubMed ID: 3890755
[TBL] [Abstract][Full Text] [Related]
30. Nanomaterials Based on Functional Polymers for Sensitizing Cancer Radiotherapy.
Lin J; Yin M; Liu X; Meng F; Luo L
Macromol Rapid Commun; 2022 Sep; 43(18):e2200194. PubMed ID: 35578790
[TBL] [Abstract][Full Text] [Related]
31. Application of High-Z Nanoparticles to Enhance Current Radiotherapy Treatment.
Jackson N; Cecchi D; Beckham W; Chithrani DB
Molecules; 2024 May; 29(11):. PubMed ID: 38893315
[TBL] [Abstract][Full Text] [Related]
32. Cancer Radiosensitizers.
Wang H; Mu X; He H; Zhang XD
Trends Pharmacol Sci; 2018 Jan; 39(1):24-48. PubMed ID: 29224916
[TBL] [Abstract][Full Text] [Related]
33. Biological modifiers as potential radiosensitizers: targeting the epidermal growth factor receptor family.
Sartor CI
Semin Oncol; 2000 Dec; 27(6 Suppl 11):15-20; discussion 92-100. PubMed ID: 11236022
[TBL] [Abstract][Full Text] [Related]
34. The Physico-Chemical Basis of DNA Radiosensitization: Implications for Cancer Radiation Therapy.
Schürmann R; Vogel S; Ebel K; Bald I
Chemistry; 2018 Jul; 24(41):10271-10279. PubMed ID: 29522244
[TBL] [Abstract][Full Text] [Related]
35. Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements.
Her S; Jaffray DA; Allen C
Adv Drug Deliv Rev; 2017 Jan; 109():84-101. PubMed ID: 26712711
[TBL] [Abstract][Full Text] [Related]
36. Targeted radiosensitization in prostate cancer.
Ghotra VP; Geldof AA; Danen EH
Curr Pharm Des; 2013; 19(15):2819-28. PubMed ID: 23448469
[TBL] [Abstract][Full Text] [Related]
37. [Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials].
Azria D; Larbouret C; Robert B; Culine S; Ychou M; Verrelle P; Dubois JB; Pèlegrin A
Bull Cancer; 2003 Nov; 90 Spec No():S202-12. PubMed ID: 14763141
[TBL] [Abstract][Full Text] [Related]
38. Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications.
Boateng F; Ngwa W
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906108
[TBL] [Abstract][Full Text] [Related]
39. Combination of radiosensitizers and hyperthermia in tumour radiotherapy.
Brückner V
S Afr Med J; 1981 Jan; 59(4):116-7. PubMed ID: 7006107
[TBL] [Abstract][Full Text] [Related]
40. The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme.
Yang D; Tan M; Wang G; Sun Y
PLoS One; 2012; 7(3):e34079. PubMed ID: 22457814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
